Tin tức & Cập nhật

Moderate coffee drinking could save lives from liver disease

05 Oct 2020 bởi

Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.

Moderate coffee drinking could save lives from liver disease

05 Oct 2020

ALBI score outperforms MELD XI for liver dysfunction assessment in acute heart failure

03 Oct 2020

The albumin-bilirubin (ALBI) score may hold value as a marker for liver dysfunction in patients with acute heart failure, a recent study reports.

ALBI score outperforms MELD XI for liver dysfunction assessment in acute heart failure

03 Oct 2020

Nidufexor lowers ALT, hepatic fat in patients with NASH

30 Sep 2020 bởi

Treatment with nidufexor led to significantly reduced serum alanine aminotransferase (ALT) levels and hepatic fat fraction in patients with nonalcoholic steatohepatitis (NASH), according to a phase II study presented at ILC 2020.

Nidufexor lowers ALT, hepatic fat in patients with NASH

30 Sep 2020

Liver cirrhosis: Repeat FIB-4 test predicts who’s at risk

29 Sep 2020 bởi

A repeat fibrosis-4 (FIB-4) test ably identifies individuals at greatest risk for liver cirrhosis in a new study.

Liver cirrhosis: Repeat FIB-4 test predicts who’s at risk

29 Sep 2020

Do β-blockers pose more harm than good in decompensated cirrhosis?

26 Sep 2020

In patients with decompensated cirrhosis, β-blockers trigger a stronger systemic haemodynamic response and exert a weaker portal pressure-lowering effect, a recent study has found.

Do β-blockers pose more harm than good in decompensated cirrhosis?

26 Sep 2020

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

24 Sep 2020

A novel nomogram that includes liver stiffness measurements may help predict postoperative complications in hepatocellular carcinoma (HCC) patients, a recent study has found.

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

24 Sep 2020

Daily albumin infusion fails to reduce infection, renal dysfunction in decompensated cirrhosis

21 Sep 2020 bởi

Daily albumin infusion to achieve serum albumin levels of ≥30 g/L did not reduce the risk of infection, renal dysfunction, or mortality in individuals with acute decompensated cirrhosis, according to results of the ATTIRE* study presented at ILC 2020.

Daily albumin infusion fails to reduce infection, renal dysfunction in decompensated cirrhosis

21 Sep 2020

Single tremelimumab priming dose exhibits acceptable safety for advanced HCC

14 Sep 2020 bởi

The novel combination regimen comprising the immune checkpoint inhibitors (ICIs) durvalumab (anti-PD-L1) and tremelimumab (anti-CTLA-4) showed a favourable safety profile and clinical activity for advanced hepatocellular carcinoma (HCC), according to detailed safety data presented at ESMO GI 2020.

Single tremelimumab priming dose exhibits acceptable safety for advanced HCC

14 Sep 2020

Acute autoimmune hepatitis a growing threat in Japan

12 Sep 2020

Acute autoimmune hepatitis appears to be increasingly prevalent in Japan, a recent study has found. New strategies for diagnosis are needed to combat an emerging public health threat.

Acute autoimmune hepatitis a growing threat in Japan

12 Sep 2020

Aldafermin significantly reduces liver fat in patients with NASH

11 Sep 2020 bởi

Treatment with an FGF19 analogue aldafermin, previously known as NGM282, led to a significantly reduced liver fat content (LFC) in patients with nonalcoholic steatohepatitis (NASH), according to a study presented at ILC 2020.

Aldafermin significantly reduces liver fat in patients with NASH

11 Sep 2020

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Moderate coffee drinking could save lives from liver disease

Moderate coffee drinking could save lives from liver disease

ALBI score outperforms MELD XI for liver dysfunction assessment in acute heart failure

ALBI score outperforms MELD XI for liver dysfunction assessment in acute heart failure

Nidufexor lowers ALT, hepatic fat in patients with NASH

Nidufexor lowers ALT, hepatic fat in patients with NASH

Liver cirrhosis: Repeat FIB-4 test predicts who’s at risk

Liver cirrhosis: Repeat FIB-4 test predicts who’s at risk

Do β-blockers pose more harm than good in decompensated cirrhosis?

Do β-blockers pose more harm than good in decompensated cirrhosis?

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

Daily albumin infusion fails to reduce infection, renal dysfunction in decompensated cirrhosis

Daily albumin infusion fails to reduce infection, renal dysfunction in decompensated cirrhosis

Single tremelimumab priming dose exhibits acceptable safety for advanced HCC

Single tremelimumab priming dose exhibits acceptable safety for advanced HCC

Acute autoimmune hepatitis a growing threat in Japan

Acute autoimmune hepatitis a growing threat in Japan

Aldafermin significantly reduces liver fat in patients with NASH

Aldafermin significantly reduces liver fat in patients with NASH